Summit Therapeutics Inc. (SMMT)

Summit Therapeutics Statistics

Total Valuation

SMMT has a market cap or net worth of $13.96 billion. The enterprise value is $14.01 billion.

Market Cap	13.96B
Enterprise Value	14.01B

Important Dates

The last earnings date was Thursday, April 30, 2026, after market close.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	n/a

Share Statistics

SMMT has 776.16 million shares outstanding. The number of shares has increased by 4.05% in one year.

Current Share Class	776.16M
Shares Outstanding	776.16M
Shares Change (YoY)	+4.05%
Shares Change (QoQ)	+1.18%
Owned by Insiders (%)	78.51%
Owned by Institutions (%)	15.25%
Float	134.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	497.74
PB Ratio	26.71
P/TBV Ratio	26.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.41, with a Debt / Equity ratio of 0.04.

Current Ratio	7.41
Quick Ratio	7.19
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -270.95% and return on invested capital (ROIC) is -166.73%.

Return on Equity (ROE)	-270.95%
Return on Assets (ROA)	-148.15%
Return on Invested Capital (ROIC)	-166.73%
Return on Capital Employed (ROCE)	-216.58%
Weighted Average Cost of Capital (WACC)	-2.65%
Revenue Per Employee	n/a
Profits Per Employee	-$4.55M
Employee Count	265
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.61% in the last 52 weeks. The beta is -1.26, so SMMT's price volatility has been lower than the market average.

Beta (5Y)	-1.26
52-Week Price Change	-25.61%
50-Day Moving Average	18.69
200-Day Moving Average	19.34
Relative Strength Index (RSI)	47.23
Average Volume (20 Days)	5,255,703

Short Selling Information

The latest short interest is 29.19 million, so 21.65% of the outstanding shares have been sold short.

Short Interest	29.19M
Short Previous Month	34.50M
Short % of Shares Out	21.65%
Short % of Float	n/a
Short Ratio (days to cover)	7.57

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.22B
Pretax Income	-1.21B
Net Income	-1.21B
EBITDA	-1.22B
EBIT	-1.22B
Earnings Per Share (EPS)	-$1.59

Balance Sheet

The company has $598.73 million in cash and $20.04 million in debt, with a net cash position of $578.69 million or $0.75 per share.

Cash & Cash Equivalents	598.73M
Total Debt	20.04M
Net Cash	578.69M
Net Cash Per Share	$0.75
Equity (Book Value)	545.93M
Book Value Per Share	0.70
Working Capital	533.33M

Cash Flow

In the last 12 months, operating cash flow was -$384.05 million and capital expenditures -$480,000, giving a free cash flow of -$384.53 million.

Operating Cash Flow	-384.05M
Capital Expenditures	-480,000
Depreciation & Amortization	165,000
Net Borrowing	n/a
Free Cash Flow	-384.53M
FCF Per Share	-$0.50

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SMMT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.05%
Shareholder Yield	-4.05%
Earnings Yield	-8.27%
FCF Yield	-2.64%

Analyst Forecast

The average price target for SMMT is $30.54, which is 69.76% higher than the current price. The consensus rating is "Buy".

Price Target	$30.54
Price Target Difference	69.76%
Analyst Consensus	Buy
Analyst Count	15
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1